Okut, Gokalp <br/><br/>
Nonmelanoma Skin Cancers After Kidney Transplant: Our 15 Years of Experience With Mammalian Target of Rapamycin Inhibitors.  [electronic resource] 

 -  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation  02 2017 
 - 236-239 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2146-8427 
<br/><br/><label>Standard No.: </label>10.6002/ect.mesot2016.p112  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Basal Cell--chemically induced<br/>Carcinoma, Squamous Cell--chemically induced<br/>Cost-Benefit Analysis<br/>Drug Costs<br/>Drug Substitution<br/>Graft Rejection--immunology<br/>Graft Survival<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Transplantation--adverse effects<br/>Medical Records<br/>Neoplasm Recurrence, Local<br/>Protein Kinase Inhibitors--adverse effects<br/>Retrospective Studies<br/>Risk Factors<br/>Sarcoma, Kaposi--chemically induced<br/>Skin Neoplasms--chemically induced<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors<br/>Time Factors<br/>Treatment Outcome